Log In
BCIQ
Print this Print this
 

AZD5634

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionInhaled epithelial sodium channel (ENaC)
Molecular Target Epithelial sodium channel (ENaC)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today